Year |
Citation |
Score |
2023 |
Turner CN, Camilo Sanchez Arcila J, Huerta N, Quiguoe AR, Jensen KDC, Hoyer KK. T cell exhaustion dynamics in systemic autoimmune disease. Biorxiv : the Preprint Server For Biology. PMID 38187518 DOI: 10.1101/2023.12.23.573167 |
0.314 |
|
2022 |
Turner CN, Mullins GN, Hoyer KK. CXCR5CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? Frontiers in Medicine. 9: 1034764. PMID 36314014 DOI: 10.3389/fmed.2022.1034764 |
0.421 |
|
2021 |
Valentine KM, Mullins GN, Davalos OA, Seow LW, Hoyer KK. CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties. Journal of Autoimmunity. 123: 102690. PMID 34274825 DOI: 10.1016/j.jaut.2021.102690 |
0.324 |
|
2019 |
Valentine KM, Hoyer KK. CXCR5+ CD8 T Cells: Protective or Pathogenic? Frontiers in Immunology. 10: 1322. PMID 31275308 DOI: 10.3389/fimmu.2019.01322 |
0.36 |
|
2018 |
Valentine KM, Davini D, Lawrence TJ, Mullins GN, Manansala M, Al-Kuhlani M, Pinney JM, Davis JK, Beaudin AE, Sindi SS, Gravano DM, Hoyer KK. CD8 Follicular T Cells Promote B Cell Antibody Class Switch in Autoimmune Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 29743314 DOI: 10.4049/Jimmunol.1701079 |
0.402 |
|
2016 |
Gravano DM, Al-Kuhlani M, Davini D, Sanders PD, Manilay JO, Hoyer KK. CD8(+) T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure. Journal of Autoimmunity. PMID 27453063 DOI: 10.1016/j.jaut.2016.07.007 |
0.337 |
|
2008 |
Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunological Reviews. 226: 19-28. PMID 19161413 DOI: 10.1111/J.1600-065X.2008.00697.X |
0.306 |
|
2006 |
Xu J, Gowen L, Raphalides C, Hoyer KK, Weinger JG, Renard M, Troke JJ, Vaitheesyaran B, Lee WN, Saad MF, Sleeman MW, Teitell MA, Kurland IJ. Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse. Diabetes. 55: 3372-80. PMID 17130482 DOI: 10.2337/Db06-0002 |
0.478 |
|
2006 |
Shen RR, Ferguson DO, Renard M, Hoyer KK, Kim U, Hao X, Alt FW, Roeder RG, Morse HC, Teitell MA. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood. 108: 1991-8. PMID 16728701 DOI: 10.1182/Blood-2006-02-001354 |
0.641 |
|
2005 |
Hoyer KK, Herling M, Bagrintseva K, Dawson DW, French SW, Renard M, Weinger JG, Jones D, Teitell MA. T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation. Journal of Immunology (Baltimore, Md. : 1950). 175: 864-73. PMID 16002684 DOI: 10.4049/Jimmunol.175.2.864 |
0.565 |
|
2004 |
Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu FT, Said JW, Baum LG, Teitell MA. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. The American Journal of Pathology. 164: 893-902. PMID 14982843 DOI: 10.1016/S0002-9440(10)63177-X |
0.657 |
|
2002 |
Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M, Malone CS, Knoetig S, Qi CF, Su TT, Cheroutre H, Wall R, Rawlings DJ, Morse HC, Teitell MA. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 99: 14392-7. PMID 12381789 DOI: 10.1073/Pnas.212410199 |
0.686 |
|
2002 |
French SW, Hoyer KK, Shen RR, Teitell MA. Transdifferentiation and nuclear reprogramming in hematopoietic development and neoplasia. Immunological Reviews. 187: 22-39. PMID 12366680 DOI: 10.1034/J.1600-065X.2002.18703.X |
0.591 |
|
2001 |
Said JW, Hoyer KK, French SW, Rosenfelt L, Garcia-Lloret M, Koh PJ, Cheng TC, Sulur GG, Pinkus GS, Kuehl WM, Rawlings DJ, Wall R, Teitell MA. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 81: 555-64. PMID 11304575 DOI: 10.1038/Labinvest.3780264 |
0.651 |
|
Show low-probability matches. |